BMJ  1989;298:784-788 (25 March), doi:10.1136/bmj.298.6676.784

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

W. Y. Craig, G. E. Palomaki, J. E. Haddow

Foundation for Blood Research, Scarborough, ME 04074.

To examine the association between cigarette smoking in adults and serum lipid and lipoprotein concentrations the results of 54 published studies were analysed. Overall, smokers had significantly higher serum concentrations of cholesterol (3.0%), triglycerides (9.1%), very low density lipoprotein cholesterol (10.4%), and low density lipoprotein cholesterol (1.7%) and lower serum concentrations of high density lipoprotein cholesterol (-5.7%) and apolipoprotein AI (-4.2%) compared with nonsmokers. Among non-smokers and light, moderate, and heavy smokers a significant dose response effect was present for cholesterol (0, 1.8, 4.3, and 4.5% respectively), triglycerides (0, 10.7, 11.5, and 18.0%), very low density lipoprotein cholesterol (0, 7.2, 44.4, and 39.0%), low density lipoprotein cholesterol (0, -1.1, 1.4, and 11.0%), high density lipoprotein cholesterol (0, -4.6, -6.3, and -8.9%), and apolipoprotein AI (0, -3.7 and -5.7% in non-smokers and light and heavy smokers). These dose response effects may provide new evidence for a causal relation between exposure to cigarette smoke and changes in serum lipid and lipoprotein concentrations whether as a direct result of physiological changes or of dietary changes induced by smoking. Adequate prospective data to estimate the excess risk of coronary artery disease existed only for cholesterol concentration. When that information was combined with data from the present study, and given that smokers as a group face an average overall excess risk of coronary artery disease of 70%, it was estimated that the observed increased serum cholesterol concentration in smokers may account for at least 9% of that excess risk. Furthermore, the dose response effect of smoking on serum cholesterol concentration suggests a gradient of increased absolute risk of coronary artery disease between light and heavy smokers.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Cigarette smoking and serum lipid and lipoprotein concentrations.
J. Cade and B. Margetts
BMJ 1989 298: 1312. [PDF]

This article has been cited by other articles:

  • Nagel, G., Arnold, F. J., Wilhelm, M., Link, B., Zoellner, I., Koenig, W. (2009). Environmental tobacco smoke and cardiometabolic risk in young children: results from a survey in south-west Germany. Eur Heart J 30: 1885-1893 [Abstract] [Full text]  
  • Leon, A. S., Bronas, U. G. (2009). Dyslipidemia and Risk of Coronary Heart Disease: Role of Lifestyle Approaches for Its Management. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 3: 257-273 [Abstract]  
  • Junyent, M., Tucker, K. L., Smith, C. E., Garcia-Rios, A., Mattei, J., Lai, C.-Q., Parnell, L. D., Ordovas, J. M. (2009). The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J. Lipid Res. 50: 565-573 [Abstract] [Full text]  
  • Rudolph, T. K., Rudolph, V., Baldus, S. (2008). Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation. Proc Am Thorac Soc 5: 820-823 [Abstract] [Full text]  
  • Viiri, L. E., Viiri, K. M., Ilveskoski, E., Huhtala, H., Maki, M., Tienari, P. J., Perola, M., Lehtimaki, T., Karhunen, P. J. (2008). Interactions of Functional Apolipoprotein E Gene Promoter Polymorphisms With Smoking on Aortic Atherosclerosis. Circ Cardiovasc Genet 1: 107-116 [Abstract] [Full text]  
  • Missel, E., Mintz, G. S., Carlier, S. G., Qian, J., Shan, S., Castellanos, C., Kaple, R., Biro, S., Fahy, M., Moses, J. W., Stone, G. W., Leon, M. B. (2008). In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J 29: 2141-2147 [Abstract] [Full text]  
  • Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., Make, B. J. (2008). Comorbidities in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 549-555 [Abstract] [Full text]  
  • Roethig, H. J., Feng, S., Liang, Q., Liu, J., Rees, W. A., Zedler, B. K. (2008). A 12-Month, Randomized, Controlled Study to Evaluate Exposure and Cardiovascular Risk Factors in Adult Smokers Switching From Conventional Cigarettes to a Second-Generation Electrically Heated Cigarette Smoking System. J Clin Pharmacol 48: 580-591 [Abstract] [Full text]  
  • Ruixing, Y., Qiming, F., Dezhai, Y., Shuquan, L., Weixiong, L., Shangling, P., Hai, W., Yongzhong, Y., Feng, H., Shuming, Q. (2007). Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations. J. Lipid Res. 48: 2673-2681 [Abstract] [Full text]  
  • Payne, J R, Eleftheriou, K I, James, L E, Hawe, E, Mann, J, Stronge, A, Kotwinski, P, World, M, Humphries, S E, Pennell, D J, Montgomery, H E (2006). Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart 92: 1784-1788 [Abstract] [Full text]  
  • Scigliano, G., Musicco, M., Soliveri, P., Piccolo, I., Ronchetti, G., Girotti, F. (2006). Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients: A Case-Control Study. Stroke 37: 1184-1188 [Abstract] [Full text]  
  • Lau, P. P., Li, L., Merched, A. J., Zhang, A. L., Ko, K. W.S., Chan, L. (2006). Nicotine Induces Proinflammatory Responses in Macrophages and the Aorta Leading to Acceleration of Atherosclerosis in Low-Density Lipoprotein Receptor-/- Mice. Arterioscler. Thromb. Vasc. Bio. 26: 143-149 [Abstract] [Full text]  
  • Hatsukami, D. K., Kotlyar, M., Allen, S., Jensen, J., Li, S., Le, C., Murphy, S. (2005). Effects of Cigarette Reduction on Cardiovascular Risk Factors and Subjective Measures. Chest 128: 2528-2537 [Abstract] [Full text]  
  • Costanza, M. C., Cayanis, E., Ross, B. M., Flaherty, M. S., Alvin, G. B., Das, K., Morabia, A. (2005). Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population. Am J Epidemiol 161: 714-724 [Abstract] [Full text]  
  • Ambrose, J. A., Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 43: 1731-1737 [Abstract] [Full text]  
  • Morabia, A., Cayanis, E., Costanza, M. C., Ross, B. M., Flaherty, M. S., Alvin, G. B., Das, K., Gilliam, T. C. (2003). Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet 12: 2733-2743 [Abstract] [Full text]  
  • Reaven, G., Tsao, P. S. (2003). Insulin resistance and compensatory hyperinsulinemia: The key player between cigarette smoking and cardiovascular disease?. J Am Coll Cardiol 41: 1044-1047 [Abstract] [Full text]  
  • Hioki, H., Aoki, N., Kawano, K., Homori, M., Hasumura, Y., Yasumura, T., Maki, A., Yoshino, H., Yanagisawa, A., Ishikawa, K. (2001). Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 22: 56-61 [Abstract]  
  • Price, J.F., Mowbray, P.I., Lee, A.J., Rumley, A., Lowe, G.D.O., Fowkes, F.G.R. (1999). Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study: Edinburgh Artery Study. Eur Heart J 20: 344-353 [Abstract]  
  • Doll, R. (1998). Uncovering the effects of smoking: historical perspective. Stat Methods Med Res 7: 87-117 [Abstract]  
  • Benowitz, N.L. (1997). Systemic Absorption and Effects of Nicotine From Smokeless Tobacco. ADR 11: 336-341 [Abstract]  
  • Hjalmarson, A., Nilsson, F., Sjostrom, L., Wiklund, O. (1997). The Nicotine Inhaler in Smoking Cessation. Arch Intern Med 157: 1721-1728 [Abstract]  
  • Hedblad, B., Ogren, M., Isacsson, S.-O., Janzon, L. (1997). Reduced Cardiovascular Mortality Risk in Male Smokers Who Are Physically Active: Results From a 25-Year Follow-up of the Prospective Population Study Men Born in 1914. Arch Intern Med 157: 893-899 [Abstract]  
  • Christen, W. G., Glynn, R. J., Manson, J. E., Ajani, U. A., Buring, J. E. (1996). A Prospective Study of Cigarette Smoking and Risk of Age-Related Macular Degeneration in Men. JAMA 276: 1147-1151 [Abstract]  
  • Klein, R., Klein, B. E. K. (1996). Smoke Gets in Your Eyes Too. JAMA 276: 1178-1179 [Abstract]  
  • Elisaf, M., Papanikolaou, N., Letzaris, G., Siamopoulos, K.C. (1996). Smoking habit in female students of northwestern Greece: relation to other cardiovascular risk factors. The Journal of the Royal Society for the Promotion of Health 116: 87-90 [Abstract]  
  • Cooper, G. R., Myers, G. L., Smith, S. J., Schlant, R. C. (1992). Blood Lipid Measurements: Variations and Practical Utility. JAMA 267: 1652-1660 [Abstract]  
  • Koskinen, P., Kovanen, P. T., Tuomilehto, J., Manninen, V. (1992). Gemfibrozil Also Corrects Dyslipidemia in Postmenopausal Women and Smokers. Arch Intern Med 152: 90-96 [Abstract]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ